NCT04540588 2025-12-02Retreatment With Intratumoral Diffusing Alpha Radiation EmittersAlpha Tau Medical LTD.Phase NA Completed2 enrolled
NCT03602079 2023-08-03Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneKlus Pharma Inc.Phase 1/2 Completed49 enrolled
NCT03239834 2021-08-12Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-MakingVigilant Biosciences, Inc.Completed893 enrolled
NCT00050388 2008-06-24Phase II Trial of Allovectin-7® for Head and Neck CancerVicalPhase 3 Completed